Binding Modes are compared using Grim.
For more information, please see the following publication:
Desaphy J. et al. Encoding Protein-Ligand Interaction Patterns in Fingerprints and Graphs J. Chem. Inf. Model., 2013, 53 (3), pp 623-637
Binding modes are considered as similar when the similarity value is greater than 0.65
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 3f6s | FMN | Flavodoxin |
| PDB ID | HET | Uniprot Name | EC Number | Binding Mode Similarity |
Align |
|---|---|---|---|---|---|
| 3f6s | FMN | Flavodoxin | / | 1.293 | |
| 1akr | FMN | Flavodoxin | / | 1.035 | |
| 1azl | FMN | Flavodoxin | / | 1.025 | |
| 1akw | FMN | Flavodoxin | / | 0.993 | |
| 1xyv | FMN | Flavodoxin | / | 0.982 | |
| 1aku | FMN | Flavodoxin | / | 0.981 | |
| 3f90 | FMN | Flavodoxin | / | 0.981 | |
| 1j8q | FMN | Flavodoxin | / | 0.976 | |
| 1wsb | FMN | Flavodoxin | / | 0.967 | |
| 1c7f | FMN | Flavodoxin | / | 0.963 | |
| 3f6r | FMN | Flavodoxin | / | 0.918 | |
| 2v5u | FMN | Flavodoxin | / | 0.910 | |
| 1j9g | FMN | Flavodoxin | / | 0.905 | |
| 1ahn | FMN | Flavodoxin 1 | / | 0.889 | |
| 1czn | FMN | Flavodoxin | / | 0.889 | |
| 2fx2 | FMN | Flavodoxin | / | 0.886 | |
| 1xyy | FMN | Flavodoxin | / | 0.871 | |
| 5tgz | FMN | Cannabinoid receptor 1 | / | 0.860 | |
| 2fcr | FMN | Flavodoxin | / | 0.852 | |
| 1ofv | FMN | Flavodoxin | / | 0.847 | |
| 4fx2 | FMN | Flavodoxin | / | 0.842 | |
| 3esz | FMN | Flavodoxin | / | 0.832 | |
| 4n82 | FMN | Ribonucleotide reductase (NrdI family protein), putative | / | 0.819 | |
| 5xra | FMN | Cannabinoid receptor 1 | / | 0.804 | |
| 3n3b | FMN | Protein NrdI | / | 0.800 | |
| 4bmp | FMN | Protein NrdI | / | 0.789 | |
| 4bmo | FMN | Protein NrdI | / | 0.778 | |
| 4oxx | FMN | Cindoxin | / | 0.777 | |
| 1tll | FMN | Nitric oxide synthase, brain | 1.14.13.39 | 0.769 | |
| 2bn4 | FMN | NADPH--cytochrome P450 reductase | / | 0.769 | |
| 2ohi | FMN | Type A flavoprotein FprA | 1 | 0.755 | |
| 3n39 | FMN | Protein NrdI | / | 0.754 | |
| 3n3a | FMN | Protein NrdI | / | 0.754 | |
| 3kap | FMN | Flavodoxin | / | 0.751 | |
| 2v5v | FMN | Flavodoxin | / | 0.750 | |
| 1fx1 | FMN | Flavodoxin | / | 0.742 | |
| 4y7c | FMN | NADPH--cytochrome P450 reductase | / | 0.731 | |
| 2ohh | FMN | Type A flavoprotein FprA | 1 | 0.730 | |
| 3qfr | FMN | NADPH--cytochrome P450 reductase | / | 0.725 | |
| 3qe2 | FMN | NADPH--cytochrome P450 reductase | / | 0.720 | |
| 5fx2 | FMN | Flavodoxin | / | 0.719 | |
| 2ohj | FMN | Type A flavoprotein FprA | 1 | 0.716 | |
| 1ja0 | FMN | NADPH--cytochrome P450 reductase | / | 0.715 | |
| 1ych | FMN | Nitric oxide reductase | 1 | 0.715 | |
| 5xr8 | FMN | Cannabinoid receptor 1 | / | 0.715 | |
| 1bu5 | RBF | Flavodoxin | / | 0.710 | |
| 4yao | FMN | NADPH--cytochrome P450 reductase | / | 0.710 | |
| 3ojw | FMN | NADPH--cytochrome P450 reductase | / | 0.709 | |
| 2hpv | FMN | FMN-dependent NADH-azoreductase | 1.7 | 0.707 | |
| 1amo | FMN | NADPH--cytochrome P450 reductase | / | 0.706 | |
| 1ycg | FMN | Nitric oxide reductase | 1 | 0.706 | |
| 2w5u | FMN | Flavodoxin | / | 0.701 | |
| 3esy | FMN | Flavodoxin | / | 0.697 | |
| 4jay | FAD | UDP-N-acetylenolpyruvoylglucosamine reductase | / | 0.697 | |
| 3mpi | FAD | Glutaryl-CoA dehydrogenase | 1.3.99.32 | 0.694 | |
| 1ja1 | FMN | NADPH--cytochrome P450 reductase | / | 0.691 | |
| 3ojx | FMN | NADPH--cytochrome P450 reductase | / | 0.691 | |
| 4h2d | FMN | NADPH-dependent diflavin oxidoreductase 1 | / | 0.690 | |
| 4dsg | FAD | Uncharacterized protein | / | 0.686 | |
| 2b3d | FAD | Modulator of drug activity B | / | 0.685 | |
| 3hr4 | FMN | Nitric oxide synthase, inducible | 1.14.13.39 | 0.682 | |
| 4j8p | FMN | Flavodoxin | / | 0.681 | |
| 3g5m | FAD | Ribosyldihydronicotinamide dehydrogenase [quinone] | / | 0.674 | |
| 3utf | FDA | UDP-galactopyranose mutase | / | 0.671 | |
| 1ycf | FMN | Nitric oxide reductase | 1 | 0.670 | |
| 2mok | FMN | Flavodoxin 1 | / | 0.669 | |
| 4m0c | FMN | FMN-dependent NADH-azoreductase 1 | / | 0.669 | |
| 4r38 | RBF | Blue-light-activated histidine kinase 2 | 2.7.13.3 | 0.667 | |
| 3e4v | FMN | Uncharacterized protein | / | 0.664 | |
| 3ukl | FAD | UDP-galactopyranose mutase | / | 0.662 | |
| 1t5b | FMN | FMN-dependent NADH-azoreductase | / | 0.661 | |
| 3kaq | FMN | Flavodoxin | / | 0.661 | |
| 3uth | FDA | UDP-galactopyranose mutase | / | 0.661 | |
| 4n65 | FMN | FMN-dependent NADH-azoreductase 1 | / | 0.659 | |
| 4r81 | FMN | Predicted NADH dehydrogenase | / | 0.659 | |
| 3rpe | FAD | Putative modulator of drug activity | / | 0.657 | |
| 4qof | FMN | Ribosyldihydronicotinamide dehydrogenase [quinone] | / | 0.657 | |
| 4u8j | FDA | UDP-galactopyranose mutase | / | 0.656 | |
| 4u8o | FDA | UDP-galactopyranose mutase | / | 0.656 | |
| 1zwl | FMN | NAD(P)H dehydrogenase (quinone) | 1.6.5.2 | 0.654 | |
| 2isk | FNR | 5,6-dimethylbenzimidazole synthase | 1.13.11.79 | 0.654 | |
| 2isl | FNR | 5,6-dimethylbenzimidazole synthase | 1.13.11.79 | 0.654 | |
| 4hia | FMN | LOV protein | / | 0.654 | |
| 4u8n | FDA | UDP-galactopyranose mutase | / | 0.654 | |
| 3utg | FDA | UDP-galactopyranose mutase | / | 0.653 | |
| 4u8m | FDA | UDP-galactopyranose mutase | / | 0.653 | |
| 3klb | FMN | Uncharacterized protein | / | 0.652 | |
| 4dsh | FDA | Uncharacterized protein | / | 0.651 | |
| 4u8l | FDA | UDP-galactopyranose mutase | / | 0.651 | |
| 1h69 | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.650 |